ATG5 and pancreatic neoplasm: Although the proximity of Beclin1 to the BRCA1 tumor suppressor gene renders the interpretation difficult particularly in these tumor types [135], such a haplo‐insufficient tumor‐suppressive activity was also observed in the Atg5+/− mouse models for pancreatic cancer [136] and AML [137].